Express Pharma

HepaStem seems most promising pipeline agent for decompensated cirrhosis due to NASH: GlobalData

HepaStem is a stem cell therapy consisting of liver-derived mesenchymal stem cells (MSC) that addresses different components of NASH disease progression.

0 250